Stockreport

Protalix BioTherapeutics to Announce Fiscal Year 2023 Financial and Business Results on March 14, 2024

Protalix BioTherapeutics, Inc. (DE)  (PLX) 
PDF Company to host conference call and webcast at 8:30 a.m. EDTCARMIEL, Israel, March 7, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharm [Read more]